Process Insights’ Post

Our Fixed Magnetic Sector Mass Spectrometer MGA 1200CS’s NEW low flow capability allows connection to small bioreactors (e.g., 250 mL) for organism characterization. This capability benefits Industrial Fermentation, Pharmaceutical Fermentation, and Mammalian Cell Culture, driving innovation and product enhancement. In Mammalian Cell Culture, the MGA 1200CS delivers extremely precise oxygen analysis, even under low flow sparge gas rates, thanks to its NEW low flow capability supporting rates down to 20 cc/min. In the Life Sciences applications, the MGA 1200CS helps maximize yields and confirms complete CIP for fermentation vessels. It ensures adherence to stringent standards, maintaining consistent, high-quality characteristics. Learn how https://lnkd.in/eVMUz7GN DOWNLOAD Datasheet https://lnkd.in/gwNMgwTt #processinsights #fermentation #foodandbeverage #gasanalysis #lifescience #lab

Laboratory Automation Market Size, Share, Industry Analysis, Trends, Report 2023-2028 The global laboratory automation market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.3% during 2023-2028. Request to Get the Sample Report: https://lnkd.in/dD-cKQ28 The growing adoption of automation to reduce the wastage of samples, consumables, and reagents; rising integration to fasten drug discovery processes; and the increasing utilization of microfluidic ships or lab-on chips in advanced biological research represent some of the key factors driving the market. Explore Full Report with Table of Contents: https://lnkd.in/daFhKsHx #laboratory #automation #imarcgroup #marketreport #marketresearch #industrynews #industryanalysis #industryreport 

Laboratory Automation Market Size, Share, Industry Analysis, Trends, Report 2023-2028 The global laboratory automation market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.3% during 2023-2028. Request to Get the Sample Report: https://lnkd.in/dD-cKQ28 The growing adoption of automation to reduce the wastage of samples, consumables, and reagents; rising integration to fasten drug discovery processes; and the increasing utilization of microfluidic ships or lab-on chips in advanced biological research represent some of the key factors driving the market. View Full Report with TOC & List of Figure: https://lnkd.in/daFhKsHx #laboratory #automation #imarcgroup #marketreport #marketresearch #industrynews #industryanalysis #industryreport 

Analytical Science and Technologies Group (ASTG) stands at the forefront of innovation in the analytical sciences, and our product line exemplifies our commitment to delivering cutting-edge solutions to industries worldwide. From gas purity verification to environmental monitoring and beyond, ASTG's diverse product line is engineered to meet the evolving needs of our clients with precision, efficiency, and reliability. Gas Purity Verification: AirBreather Systems™ At the heart of our product line is the revolutionary AirBreather Systems™. Developed in response to the demand for advanced gas purity verification, these systems are the result of five years of meticulous development, including field trials and in-service validation. The AirBreather Systems™ redefine the standards for gas purity verification, offering a robust, economical, and maintenance-friendly solution that ensures fast, accurate, and readily accessible results. Ultra High Purity Monitoring: ASTG's Ultra High Purity (UHP) gas monitoring systems take precision to new heights. Designed for industries where even trace impurities can have significant impacts, these systems incorporate state-of-the-art technology and proprietary software. The result is unmatched accuracy in monitoring and maintaining the purity of gases vital to applications in semiconductor manufacturing, medical processes, and more. Laser Gas Cabinets: In the realm of laser applications, ASTG introduces Laser Gas Cabinets, providing a secure and controlled environment for laser gas usage. Equipped with advanced safety features such as gas leak detection systems and emergency shutdown mechanisms, these cabinets ensure the safety and precision required for applications like laser spectroscopy and cutting. Atmospheric Monitoring Cart (AMC): The Atmospheric Monitoring Cart (AMC) is ASTG's mobile solution for industries that demand real-time air quality monitoring. With the ability to detect trace amounts of toxic compounds, the AMC safeguards air purity in production facilities, offering immediate insights for informed decision-making. Laboratory Services: ASTG's laboratory services represent the pinnacle of precision in analytical testing. From environmental monitoring to materials analysis, our laboratories, equipped with cutting-edge instruments, provide comprehensive analytical solutions. Our team of experts ensures that clients receive accurate and reliable results to support their decision-making processes. Semiconductor Business Expansion: ASTG's expanding semiconductor business is a testament to our resilience and adaptability in the face of extreme supply chain challenges. With a wealth of experience, adaptability, and innovative solutions, ASTG is positioned as a reliable partner for industries navigating the complexities of the semiconductor landscape. Learn more at : www.ASTG.com

#AnalyticalInstrumentation Industry is projected to witness a CAGR of 4.8% during the period 2023-2032. This growth can be attributed to the increasing adoption of analytical instrumentation for precision medicine applications.

🔬 Elevating Pharma Manufacturing: The Power of CFD! 🌟 We're excited to unravel the transformative influence of Computational Fluid Dynamics (CFD) in pharmaceutical manufacturing. 🏭✨ Computational Fluid Dynamics, or CFD, isn't just an acronym – it's a catalyst for change. 🚀 It's redefining how we enhance quality and sustainability in classified areas of pharmaceutical plants, both in design and operations. 💡 Imagine this: In the early design stages, CFD empowers us to predict the real-world performance of HVAC systems, safeguarding critical zones in manufacturing. It's like having a crystal ball that spots ventilation inefficiencies, first-air disruptions, and potential contamination risks ahead of time. This translates to improved plant quality, robustness, and reduced hazards. 🔬 CFD breaks free from "magic numbers" and "rule of thumb" approaches, introducing a scientific edge to design. But its impact doesn't stop there – CFD output also optimizes HVAC systems, curbing energy consumption and shrinking carbon footprints. 🌍🌱 And that's not all – CFD aligns seamlessly with Contamination Control Strategies (CCS) and drives conscious, science-backed decisions through the lens of Quality Risk Management (QRM). 📚 Ready to dive deeper into the world of CFD and its role in pharmaceutical innovation? Read insights by Pier Angelo Galligani, Head of Sustainability and Innovation Depts. and Founder at Techniconsult Group 👇 https://hubs.ly/Q023KfzY0 And join our TEQ Talk and unlock the full potential 👇 https://hubs.ly/Q023Kw9C0. Let's embark on a journey of discovery, innovation, and sustainable progress together! #PQEGroup #TechniconsultFirenze #TEQTalk #CFDRevolution #QualityAndSustainability #HVACOptimization #sustainability

#AnalyticalInstrumentation Industry is projected to witness a CAGR of 4.8% during the period 2023-2032. This growth can be attributed to the increasing adoption of analytical instrumentation for precision medicine applications.

It’s a new year, and Stratedigm is already setting the stage for another record-breaking year of innovation and product launches. Since our inception, we have consistently introduced innovative solutions that have transformed the landscape of flow cytometry automation. In 2023, the A640 Cell Prep Module (CPM) and the A810 Cell Incubator (CI) were the stars, offering effortless bulk reagent handling and automation for assays requiring incubation at multiple temperatures. Above all, we were most excited and proud to introduce our Flowraissance program. With complimentary upgrades to Stratedigm’s latest hardware and software platform for S1000 cytometers that are 10 years or older, it delivers assured instrument longevity and unrivaled performance. On the heels of these unique offerings, 2024 will be another groundbreaking year, as we plan to release a series of cutting-edge instruments and software features: - Expansion of our automation suite: we will continue to expand our already comprehensive automation suite with the launch of a new instrument. This addition will further streamline and enhance your research experience, providing unparalleled efficiency and precision in your laboratory. - Enhanced CellCapTure software capabilities: expect our CellCapTure software to make the next step to intelligent, high-throughput flow cytometry with expanding AI-based optimization of multi-plate experiments for faster speed and higher throughput of our automation suite. - Launch of the next S1000 platform with capabilities in the area of spectral flow cytometry: this next stage of our S1000 flow cytometry platform will offer a seamless transition from foundation to spectral analysis, a more powerful engine for optimization of pre-analytical steps, and a ten-fold increase in gain adjustment. As we continue to break records and redefine the industry, Stratedigm remains committed to providing you with the most advanced and innovative solutions for your research needs. We look forward to sharing more details about these exciting new developments in the coming months. Stay tuned! https://lnkd.in/grdc4kDP

Discover the transformative power of CFD simulation in bolstering Contamination Control Strategies (CCS), Quality Risk Management (QRM), and sustainability within pharmaceutical facilities through this 5-minute read article.